- Friday, December 2: Michael Abend, MD, PhD, deputy director and group leader, “Radiation Epidemiology,” Institute of Radiobiology of the German Armed Forces, Munich, Germany: Correcting false gene expression measurements from degraded RNA using RTQ-PCR.
- Friday, November 18: Alexandra C. Miller, PhD, Scientific Research Department, AFRRI: Deleted uranium and transgenerational effects: A review of preconceptional paternal exposure to radiation, heavy metals, and current studies.
- Friday, October 21: Terry Pellmar, PhD, Scientific Director, AFRRI: Transformation of the science directorate.
- Friday, September 30: Pataje G.S. Prasanna, PhD, Biodosimetry Team, AFRRI: Cytogenetic biodosimetry laboratory automation and laboratory information management system.
- Friday, September 16: Scott A. Wilson, MAJ, USA, assistant joint product manager, Medical Identification and Treatment Systems, Chemical Biological Medical Systems, Joint Program Executive Office for Chemical/Biological Defense, Frederick, MD: Department of Defense acquisition overview.
- Friday, September 9: Pawan Sharma, PhD, senior research scientist, Immunology Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India: Modulation of dendritic cells by mycobacterial secretory protein.
- Thursday, September 1: C.K.K. Nair, Head, Radiation Biochemistry Section, Radiation Biology and Health Science Division, Bhabha Atomic Research Centre, Mumbai, India: Natural and synthetic drugs with potential for radioprotection in humans.
- Thursday, July 28: Cameron Koch, MD, Radiation Biology Branch, Department of Radiation Oncology, UPENN, Philadelphia: Oxygen and its interaction with radioprotectors.
- Friday, July 22: Charles A. Salter, LTC, USA, Biodosimetry Team, AFRRI: Presenting radiation casualty management at a military medicine conference in Vietnam.
- Friday, July 1 (DoD only): K. Sree Kumar, PhD, Radiation Casualty Management Team, AFRRI: Radioprotection by tocols: Role of cytokine induction.
- Friday, June 24 (DoD only): Mark H. Whitnall, PhD, Radiation Casualty Management Team, AFRRI: Evaluation and development of radiation countermeasures at AFRRI.
- Friday, May 27: Glen L. Manglapus, CPT, USA, Biodosimetry Team, AFRRI: Transcriptional regulators of progenitor cells in the rat olfactory epithelium.
- Friday, May 20: Andreas M. Papas, PhD, president, YASOO Health, Inc., Johnson City, TN: Vitamin E: A new perspective.
- Friday, April 29 (DoD only): Alexandra Miller, PhD, Radiation Casualty Management Team, AFRRI: Chemoprevention of radiation-induced cancer: Development of a molecular biomarker-based strategy.
- Thursday, April 28: Bobby R. Scott, PhD, Lovelace Respiratory Research Institute, Albuquerque, NM: Residual risks for lethality after application of medical countermeasures against damage from inhaled γ-emitting radionuclides released from a radiological weapon.
- Friday, April 22 (DoD only): Michael O. Shoemaker, PhD, Research Microbiologist/Pharmacologist, Radiation Infection Treatment Team, AFRRI: Antimicrobial efficacy of ciprofloxacin and genistein: Preliminary studies.
- Friday, April 8: Juliann G. Kiang, PhD, Professor of Medicine and Pharmacology, Walter Reed Army Institute of Research (WRAIR) and USUHS: Geldanamycin inhibits apoptosis in organs of hemorrhaged mice: iNOS, caspase-3, ATP.
- Friday, March 25 (DoD only): Venkataraman Srinivasan, PhD, Research Biologist, Radiation Casualty Management Team, AFRRI: Evaluation of non-toxic agents and drugs as radioprotectants in mice.
- Friday, March 18 (DoD only): Gregory L. King, PhD, Research Physiologist, Radiation Infection Treatment Team, AFRRI: Probiotic plus antibiotic treatment for γ-irradiated and infected mice: Preliminary studies.
- Friday, March 4 (DoD only): R. Joel Lowry, PhD, Radiation Infection Treatment Team, AFRRI: Virus infection and radiation—Puzzling the pathways.
- Tuesday, March 1: Len Connell, PhD, and Lawrence Trost, PhD, National Security Studies Department, Sandia National Laboratories, Albuquerque, NM: A risk-based approach to RDD (radiation dispersal device) threat analysis.
- Friday, February 25 (DoD only): John F. Kalinich, PhD, Research Biochemist, Heavy Metals Research Team, AFRRI: Development of a colorimetric test for uranium.
- Friday, February 18 (DoD only): William F. Blakely, PhD, Team Leader, Biodosimetry Team, AFRRI: Biological dosimetry team research and service program.
- Friday, February 11: Itzhak Brook, CDR, USN, Research Infection Treatment Team, AFRRI: Effect of nuclear detonations on large biological specimens (swine). Results of Operation Plumbob—1957.
- Friday, February 4 (DoD only): Michael R. Landauer, PhD, Research Toxicologist, Radiation Casualty Management Team, AFRRI: Radioprotective efficacy of soy isoflavones.
- Friday, January 28 (DoD only): Marcy Grace, PhD, Research Molecular Biologist, Biodosimetry Team, AFRRI: Candidate gene-expression biomarker assay validation and biodosimeter instrumentation.
- Friday, January 21 (DoD only): G. David Ledney, PhD, Acting Team Leader, Radiation Infection Treatment Team, AFRRI: Combined injury: Past, present, and the future.
- Friday, January 14 (DoD only): Thomas B. Elliott, PhD, Research Microbiologist, Radiation Infection Treatment Team, AFRRI: Research objectives of the revised RIT DTO.
- Friday, January 7: David E. McClain, PhD, Team Leader, Heavy Metals Research Team, AFRRI: Research objectives and projects of the AFRRI Heavy Metals Research Team.
|
